Lɛ wi lan bɔt T-sɛl Limfoma insay simpul wɔd dɛn. I tan lɛk se dɔktɔ ɛn yu padi de tɔk to yu!

Sɔntɛnde, yu kin fil taya ɛn taya fɔ no rizin? Ɔ yu kin gɛt smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl. Sɔntɛnde yu kin notis bak strenj spat ɔ pat na yu skin. Nɔto ɔltɛm dɛn tin ya kin sho se yu gɛt ɛnitin we siriɔs, bɔt sɔm tɛm dɛn de, dɛn tin ya kin gɛt fɔ du wit wan sik we dɛn kɔl T-cell Lymphoma . So, mek wi tok abaut dis fo likl mo ditel tide, bot rili simpul, okay? Nɔ fred, di tin we impɔtant pas ɔl na fɔ no.

Wetin na T-sɛl Limfoma?

Fɔ tɔk am simpul wan, T-cell lymphoma na wan kayn kansa we dɛn kɔl non-Hodgkin lymphoma . Wi gɛt wan spɛshal kayn wayt blɔd sɛl we dɛn kɔl T sɛl na wi bɔdi. Dis na di men sojaman dɛm fɔ wi imyun sistɛm, we de protɛkt wi frɔm sik ɛn infɛkshɔn. So, fɔ sɔm rizin, dɛn T sɛl ya kin sheb nɔmal wan, dɛn kin bɔku we dɛn nɔ kin ebul fɔ kɔntrol dɛnsɛf, ɛn dɛn kin gɛt kansa, ɛn na dat kin mek dɛn gɛt T-sɛl limfoma.

Dis kansa de divεlכp na di lymphoid tisu dεm na wi bכdi. fכ egzampl, i kin apin na say dεm lεk di limf no dεm (dεn kin kכl am bak limf no dεm), skin, di gεstrointestinal trakt , εn splin . di imכtant tin na dat, bכku difrεn sכbtayp dεm de fכ T-sεl limfoma. So, di tritmεnt kin difrεn dipכnt pan di sכbtayp.

Us kayn T-sεl limfoma de?

Dɔktɔ dɛn kin grup T-sɛl limfoma dɛn to tu kayn, i kin dipen pan aw dɛn kin skata kwik kwik wan:

1. Agresiv kayn dɛn

2. Indolent kayn dɛn

Naw, lɛ wi luk ɛni wan pan dɛn kategori ya wan bay wan.

Agresiv T-sεl limfoma dεm

Dɛn wan ya na sɔbspɛshal dɛn we de gro kwik kwik wan ɛn we de skata.

• Adult T-cell lymphoma/leukemia (human T-cell lymphotropic virus type I positive) : Dis na di kayn we we kin apin mɔ pan big pipul dɛn. I kin afɛkt di skin ɛn di bon dɛn. I gɛt fɔ du wit wan vayrɔs we dɛn kɔl human T-cell lymphotropic virus type I.
• Anaplastic large cell lymphoma (ALCL) : Dis kin bi sistεmik כ limited to di skin ( cutaneous ). rεli rεli, wan sכbtayp ALCL de we de asai wit brεst implant.
• Angioimmunoblastic T-cell lymphoma (AITL) : Dis kayn kin prɛzɛnt wit simptom dɛn we fiba ɔtoimyun dizayd , lɛk ɔtoimyun ɛmolaytik anemia (AIHA) .Kכndishכn dεm lεk imyun trombosaytopenia (ITP) .
• Enteropathy-associated T-cell lymphoma : As di nem sho, dis na wan kayn limfoma we de divεlכp na di intestines.
• di εpatosplenik gamma/delta T-sεl limfoma : Dis kin mεntal afekt di liva εn di splin.
• Nasal NK/T-cell lymphoma : NK na ɔda kayn wayt blɔd sɛl we dɛn kɔl natura kil sel , we sכm kayn we lεk T sεl dεm. dis limfoma kin afekt di layn na di nos εn di כp pat pan di briz, bכt sכmtεm i kin divεlכp na di skin כ di dijestiv trakt.
• Pεrifεral T-sεl limfoma, we dεn nכ spεsifiket כda we (PTCL-NOS) : Dis na sכm jεnarכl kεtכgrεf. Dɔktɔ dɛn kin gɛt di kayn T-sɛl limfoma we nɔ fit insay di patikyula sɔbtayp dɛn we wi bin dɔn tɔk bɔt.

Indolent T-sεl limfoma dεm

Dis na sɔbspɛshal dɛn we de gro ɛn spre sloslo pas di kayn dɛn we wi bin dɔn tɔk bɔt.

• Cutaneous T-cell lymphoma (CTCL) : Dis na di kayn T-sεl limfoma we kכmכn pas כl. Mycosis fungoides ɛn Sézary syndrome de pan dis grup. Dɛn kin afɛkt di skin mɔ.
• T-sεl prolymphocytic leukemia : Dis na כda sכbtayp we de gro sכmtεm.
• sכbkutan pannikulitis lεk T-sεl limfoma : Dis de afekt di fεt tisu dεm we de dכn di skin.

Wetin na di sayn dɛm wae de sho se yu gɛt T-sɛl limfoma?

Bikɔs T-sɛl limfoma kin afɛkt difrɛn pat dɛn na di bɔdi, di sayn dɛn kin difrɛn difrɛn wan bay usay di sik bigin. fכ egzampl, cutaneous T-cell lymphoma kin mek yu skin rεd, it כ spat dεm na di skin.

Sɔm ɔda sayn dɛm wae kin kam pan pɔrsin na:

• Fɔ swet pasmak na nɛt : Nɔto jɔs fɔ swet, bɔt fɔ swet sote di sheet dɛn kin wet.
• Pen na di bɛlɛ, bon, ɔ chɛst : Pen we de kɔntinyu fɔ de, we pɔsin nɔ ebul fɔ ɛksplen.
• Fɔ taya ɔltɛm : Fɔ fil taya pas aw yu kin fil, lɛk se yu nɔ gɛt ɛnaji ivin we yu wek na mɔnin, fɔ sɔm dez we yu nɔ gɛt ɛni rizin.
• Swollen lymph nodes : Na swɛlin we nɔ de pen na di nɛk, armpit, ɛn groin we kin fil lɛk lump.
• Fiva we nɔ ɛksplen : Fiva kin apin we di bɔdi de fɛt infɛkshɔn. If fiva nɔ go dɔŋ afta tu awa tritmɛnt na os, ɔ if di fiva kɔntinyu fɔ pas tu dez, na sayn fɔ wɔri bɔt.
• We yu de lɔs yu wet fɔ natin: Yu de lɔs yu wet we yu nɔ tray ɔ kɔntrol di it we yu de it. If yu lɔs pas 10% pan yu ɔl bɔdi wet insay siks mɔnt, na sɔntin we yu fɔ tɛl dɔktɔ bɔt.

Mɛmba se, bɔrku tɛm yu kin si dɛn sayn ya pan ɔda sik dɛm wae nɔr kin siriɔs. If yu gɛt wan ɔr mɔr pan dɛn sik ya nɔr min se yu gɛt T-sɛl limfoma. Bɔt if dɛn sik ya, mɔ di fiva ɛn di limf no dɛm we dɔn swel, de fɔ pas tu wiks, i go fayn ɔltɛm fɔ go to dɔktɔ fɔ advays.

Wetin kin mek pɔsin gɛt T-sɛl limfoma?

Nɔ wan, difinitiv kɔz nɔ de fɔ T-sɛl limfoma. Fɔ tɔk am simpul wan, na di chenj dɛn we de apin (dɔktɔ dɛn kɔl dɛn mutation ) na di jin dɛn we de kɔntrol di T-sɛl dɛn we de gro ɛn wok, ɛn dis kin mek di T-sɛl dɛn we nɔ de wok fayn. Dɔktɔ dɛn nɔ ɔndastand gud gud wan wetin mek dis kin apin, bɔt dɛn biliv se di chenj dɛn we dɛn kin gɛt na di jɛnɛtiks kin apin. (Dis na chenj dεm we wi de divεlכp as tεm de go, nכto tin dεm we dεn bכn wi wit).

Bɔt sɔm tin dɛn de we kin mek pɔsin gɛt dis sik. Risk factor na sɔmtin wae de mek pɔrsin gɛt mɔr chans fɔ gɛt sɔm kayn sik.

• Ej : Jɛnɛral wan, pipul dɛm wae dɔn pas 55 ia kin gɛt dis sik pas yɔŋ pipul dɛm.
• Jɛnda : Man dɛn kin gɛt T-sɛl limfoma smɔl pas uman dɛn.
• Ras : Sɔm stɔdi dɔn sho se dis sik kin mɔs pan sɔm rays (e.g., wayt ɔ Eshian pipul dɛm, we yu kɔmpia am wit blak pipul dɛm).
• Fɔ gɛt sɔm sik dɛn we pɔsin kin gɛt we i de fɛt insɛf .
• We pɔsin gɛt tin dɛn we kin mek pɔsin gɛt kansa . Fɔ ɛgzampul, fɔ lɔng tɛm we pɔsin de na di san pasmak (espɛshali UV layt ) ɔ we pɔsin de pan sɔm kemikal dɛn na di wokples.

Aw dɛn kin no se pɔsin gɛt T-sɛl limfoma?

If dɔktɔ tink se yu gɛt T-cell lymphoma, dɛn kin du bɔku tɛst fɔ no if yu gɛt am.

• kכmplit bכdi kכnt (CBC) wit difrεns : Dis de tεst di difrεn tכp sεl dεm na di bכdi εn dεn amoun.
• kכmprεhεnsiv mεtabolik panεl (CMP) : I de chεk di fכnshכn εn kεmikכl bεlε fכ di imכtant כgan dεm na di bכdi (lεk di liva εn di kidni dεm).
• lactate dehydrogenase (LDH) test: di lεvεl dεm fכ dis εnzym kin εlevεt insay sכm limfoma dεm.
• Peripheral blood smear : Dɛn kin chɛk blɔd sɛmpul ɔnda maykroskɔp fɔ chɛk di shep ɛn di kayn we aw di sɛl dɛn tan.
• Test fɔ sɔm vayrɔs dɛn: fɔ ɛgzampul , Epstein Barr vayrɔs , human immunodeficiency virus (HIV) ., mɔtalman T-sɛl limfotropik vayrɔs tayp I , ɔ difrɛn epataytis vayrɔs dɛn.
• di bon mכro aspirashכn εn bayopsi : dεn kin du dis fכ si if di limfoma dכn spre to di bon mכro.
• Immunophenotyping : dis tεst de εp fכ no spεsifi k protin dεm we de na di T-sεl dεm εn spεshal fכ no di kayn limfoma.
• Magnɛtik rɛsɔnans imej (MRI) skan.
• Pozitron emishɔn tomografi (PET) skan.

Dɛn tɛst ya kin mek dɔktɔ dɛn no klia wan if yu gɛt limfoma, if na so, us kayn i gɛt, ɛn aw fa i dɔn skata.

Wetin na di stej dɛm fɔ T-sɛl limfoma?

Afta dɛn dɔn no se pɔsin gɛt kansa, di dɔktɔ dɛn kin disayd aw i "stej." Dis kin min aw fa di kansa dɔn skata na di bɔdi. Fɔ no dis stej impɔtant fɔ plan tritmɛnt ɛn asɛs di prɔgnosis. Fכ men stej dεm de fכ T-sεl limfoma:

• Stej I : di limfoma de כnli na wan limf node rijyכn, כ na wan כgan na di limf sistεm, lεk di taymus gland, splin, כ bon mכro.
• Stej II : Di limfoma de insay tu ɔ mɔ grup dɛn we de na di sem say na yu dayafragm (di mɔsul bitwin yu chɛst ɛn yu bɛlɛ).
• Stej III : di limfoma de na di limf no dεm we de oba εn dכn di dayafragm, na di tu say dεm. Ɔ i kin de na di splin.
• Stej IV : di limfoma dεn dכn spre to atכs wan כgan we de ausayd di limfatik sistεm (e.g., bon mכro, liva, lכng).

כltu, sכmtεm dεn kin yuz sכmtεm difrεn stej sistεm fכ di kכtan T-sεl limfoma biכs di we aw i de spre difrεn frכm כda kayn limfoma.

Aw dɛn kin trit T-sɛl limfoma?

Di tritmɛnt fɔ T-sɛl limfoma kin difrɛn frɔm wan pɔsin to ɔda pɔsin ɛn frɔm wan kayn limfoma to ɔda kayn limfoma. Fɔ sɔm indolent kayn pipul dɛm, if nɔr simptom nɔr de fɔs, dɔktɔ kin yuse wan strateji wae dɛn kɔl "watchful waiting/active surveillance." Dis min se dɛn nɔ de trit di pɔsin wantɛm wantɛm, bɔt dɛn de wach am gud gud wan. Dɛn kin jɔs bigin fɔ trit am if di sik de kam ɔr de sik de wɔs.

Ɔda tritmɛnt dɛn kin bi:

• Kimotɛrapi : Dis na pawaful mɛrɛsin tritmɛnt we de kil kansa sɛl dɛn. Na di men tritmɛnt fɔ nɔ-Hɔdgkin limfoma, we inklud bak T-sɛl limfoma.
• Targeted therapy : Dɛn tritmɛnt ya de tɔch ɛn atak spɛshal mɔlyul dɛn pan kansa sɛl dɛn. Mɔnoklɔnal antibɔdi tɛrapi na ɛgzampul fɔ dis.
• Immunotherapy : Dɛn kin kɔl am bak biologic therapy , dis kin min fɔ mek yu bɔdi in yon imyun sistɛm ɛp fɔ fɛt di kansa sɛl dɛn. CAR T-sεl tεrapi na wan advans tritmεnt na dis fil.
• Radieshɔn tɛrapi : Dɛn kin yuz rayt we gɛt bɔku ɛnaji (lɛk ɛkstrem rayt) fɔ pwɛl di kansa sɛl dɛn.
• Kimotɛrapi wit stem sɛl transplant : Stem sɛl na blɔd sɛl dɛn we nɔ machɔ na yu blɔd ɔ bon mɛro. Afta yu dɔn tek bɔku kemotɛrapi, sɔntɛnde dɔktɔ dɛn kin transplant stem sɛl dɛn frɔm yu ( autologous stem cell transplantation ). rεli, stεm sεl dεm frכm כda mεch dכna kin transplant ( allogeneic stem cell transplantation ).

Sɔntɛnde, di wan dɛn we sik kin gɛt di chans bak fɔ tek pat pan klinik trial, usay dɔktɔ dɛn de du risach bɔt nyu tritmɛnt dɛn.

Yu tink se dɛn kin mɛn di T-sɛl limfoma ɔltogɛda?

Dis na kwɛstyɔn we bɔku pipul dɛn kin aks. Sɔm kayn T-sɛl limfoma kin go insay rɛmishɔn afta tritmɛnt. Rimishɔn min se yu nɔ gɛt ɛni sayn ɛn tɛst nɔ sho ɛni sayn fɔ di sik. Sɔm kayn kansa kin ivin wɛl ɔl afta we dɛn dɔn lɛf fɔ gɛt am fɔ lɔng tɛm. Dis kin bi fɔ sɔm kayn T-sɛl limfoma.

Bɔt, T-sɛl limfoma kin gɛt chans fɔ kam bak afta dɛn dɔn trit am . So, if yu gɛt T-sɛl limfoma, yu dɔktɔ go advays yu fayn fayn wan bɔt di kayn sik ɛn aw yu go gɛt di sik.

Wetin na di prɔgnosis fɔ T-sɛl limfoma?

"Prognosis" na wan aidia we dכkta dεn de gi yu bכt wetin fכ εkspεkt we yu de liv wit T-sεl limfoma. Bɔku tɛm dis kin bi bay di ɛkspiriɛns ɛn data we wan big grup pan di sik pipul dɛn gɛt. So, wetin dɔn bi tru fɔ ɔda pipul dɛn nɔ go rili afɛkt yu di sem we. So, na yu dɔktɔ nɔmɔ go ebul fɔ gi yu di kɔrɛkt ɛn yu yon infɔmeshɔn bɔt yu tumara bambay .

Yu tink se dɛn kin ebul fɔ mek dɛn nɔ gɛt T-sɛl limfoma?

Bikɔs dɛn nɔ stil no di rayt tin we kin mek pɔsin gɛt T-sɛl limfoma, i nɔ kin izi fɔ mek dɛn nɔ gɛt am kpatakpata. Bɔt sɔm tin dɛn de we kin mek yu gɛt prɔblɛm we yu kin kɔntrol, lɛk aw wi bin dɔn tɔk bɔt. Fɔ ɛgzampul, fɔ avɔyd fɔ gɛt tin dɛn we kin mek yu gɛt kansa, fɔ protɛkt yusɛf frɔm sɔm sik dɛn, ɛn fɔ liv fayn layf.

Aw e tan lɛk fɔ liv wit T-sɛl limfoma?

Bikɔs bɔku kayn T-cell lymphoma de, fɔ liv wit dis sik nɔr kin bi di sem fɔ ɔlman. I at fɔ tɔk di rayt we aw i tan. If yu gɛt T-sɛl limfoma, yu kin tink bɔt fɔ kia fɔ yu we nɔ de mek yu fil pen . Palliative care na spɛshal kia wae de ɛp pipul dɛm wae de liv wit siriɔs sik fɔ ridyus di sayn dɛm, kɔntrol pen, fɔ kɔntinyu fɔ gɛt strɔng maynd, ɛn fɔ mek dɛn kwaliti fɔ liv bɛtɛ. Yu kin gɛt dis palliativ kia yu wan ɔr wit T-sɛl limfoma tritmɛnt.

Aw a go kia fɔ misɛf na os?

Fɔ kia fɔ yusɛf rili impɔtant fɔ kɔntrol yu sik. Pan ɔl we dɛn tin ya nɔ go mek di sik go ɔlsay, dɛn kin ɛp yu fɔ gɛt trɛnk ɛn kɔnfidɛns fɔ liv wit am:

• It it we gɛt fayn fayn tin dɛn fɔ it : Fɔ it na ɛnaji. If yu it tin dɛn we balans, dat kin ɛp fɔ mek yu bɔdi kɔntinyu fɔ gɛt trɛnk. If nid de, tɔk to pɔsin we sabi bɔt it ɛn gɛt advays bɔt aw fɔ it we fit yu.
• Gɛt bɔku rɛst as yu ebul : Tritmɛnt lɛk kemotɛrapi kin mek yu fil taya bad bad wan. I impɔtant fɔ lɛ yu bɔdi rɛst bak ɛn gɛt trɛnk bak.
• Ɛksesaiz : Layt, nɔr strɛs ɛksesaiz (as dɔktɔ tɛl yu) kin ɛp fɔ ridyus strɛs ɛn fɔ mek yu bɔdi gɛt trɛnk.

Ustɛm a fɔ go to di dɔktɔ? / Ustɛm a fɔ go na di Imejɛnsi Dipatmɛnt (ETU) ?

• If yu notis nyu simptom ɔ chenj na yu T-sɛl limfoma we kin de wɔs (e.g., nyu lumps, ay fiva, we yu de lɔs bɔku bɔku wet), go to yu dɔktɔ wantɛm wantɛm.
• If di sayd ɛfɛkt dɛn we di tritmɛnt gɛt nɔ stɔp afta yu dɔn tek di mɛrɛsin we di dɔktɔ gi yu , i tranga pas aw yu bin de tink, ɔ i las fɔ lɔng tɛm, yu fɔ go na di Imejɛnsi Dipatmɛnt (ETU) .

Us kwɛstyɔn dɛn a fɔ aks di dɔktɔ?

Yu kin gɛt bɔrku kwɛstyɔn ɛn wɔri wae yu de no ɛn trit yu T-sɛl limfoma. I impɔtant fɔ tɔk bɔt dɛn tin ya wit yu dɔktɔ. Na sɔm kwɛstyɔn dɛn we yu kin aks:

• Us kayn T-sɛl limfoma a gɛt ɛksaktɔli?
• Wetin na di stej fɔ mi sik?
• Wetin na di men gol fɔ mi tritmɛnt?
• Us tritmɛnt dɛn yu kin kɔmɛnt fɔ mi? Wetin du?
• Wetin na di sayd ɛfɛkt dɛn we dɛn tritmɛnt ya kin gɛt? Aw dɛn go ebul fɔ kɔntrol dɛn?
• A fɔ tink bɔt fɔ tek pat pan wan klinik trial? Wetin na di bɛnifit dɛn we a gɛt?

Yu tink se T-sɛl limfoma kɔmɔn?

Nɔ, T-sɛl limfoma nɔto rili kɔmɔn kayn kansa. Fɔ ɛgzampul, di American Cancer Society se dɛn tink se na lɛk 89,000 nyu pipul dɛn we gɛt limfoma na Amɛrika nɔmɔ bay 2023. Bɔt na 10% nɔmɔ pan ɔl di limfoma dɛn we gɛt T-sɛl limfoma. Dat na lɛk 8,000 nyu kes dɛn ɛvri ia.

Wetin na di difrɛns bitwin B-sɛl limfoma ɛn T-sɛl limfoma?

Fɔ tɔk am simpul wan, B-sɛl limfoma ɛn T-sɛl limfoma de afɛkt tu difrɛn kayn limfosayt dɛn (wan kayn limf sɛl) na wi imyun sistɛm. B-sεl limfoma na wan kayn kεnsar we kכmכn pas T-sεl limfoma.

Kansa na kɔmplikɛt tin, mɔ if na kansa we nɔ kin bɔku lɛk T-sɛl limfoma. Yu kin gɛt bɔrku kwɛstyɔn ɛn de wɔnda usai fɔ fɛn infɔmeshɔn bɔt dis sik. Nɔ ɛva fred, ɛn aks yu mɛdikal tim fɔ ɛp fɔ ɔndastand aw yu gɛt di sik, aw fɔ trit yu, ɛn ɛni ɔda tin we yu go nid . Dɛn na di bɛst ɛn trɔst sɔs fɔ infɔmeshɔn, inklud wetin fɔ ɛkspɛkt frɔm yu kansa tritmɛnt.

Di tin dɛn we impɔtant pas ɔl fɔ mɛmba frɔm dis atikul (Take-Home Message) .

Okay, so, frɔm wetin wi dɔn tɔk bɔt T-cell Lymphoma, na sɔm pan di impɔtant tin dɛm wae yu nid fɔ mɛmba:

• T-sεl limfoma na wan kayn kεnsar we kin apin we di T-sεl dεm, we na imכtant pat pan wi imyun sistεm, de gro abnכmal εn we wi nכ de kכntro.
• Bɔku sɔbtayp dɛn de fɔ dis, lɛk agresiv ɛn indolent, ɛn di tritmɛnt dɛn kin difrɛn akɔdin to dat.
• If yu gɛt sɔm sayn dɛm lɛk fiva we de kɔntinyu, limf no dɛm we de swel, taya pasmak, yu de swet pasmak na nɛt, ɛn yu de lɔs yu wet we yu nɔr ɛksplen, i rili impɔtant fɔ tɛl dɔktɔ bɔt dis.
• Di tritmɛnt we dɛn kin pik kin difrɛn; kemotɛrapi, redyushɔn tɛrapi, targeted therapy, ɛn immunotherapy na di kayn sik, stej, ɛn ɔl di wɛlbɔdi we di pɔsin gɛt.
• Nɔto ɔl di T-sɛl limfoma dɛn na di sem, so na yu dɔktɔ nɔmɔ go ebul fɔ ɔndastand yu sik, di tritmɛnt, ɛn aw yu go si yu.
• Tɔk to yu dɔktɔ opin wan, aks kwɛstyɔn dɛn, ɛn tɛl yu aw yu de fil.

Mɛmba se nɔto yu wan de pan dis waka. Yu gɛt di sɔpɔt we dɔktɔ dɛn, nɔs dɛn, fambul dɛn, ɛn padi dɛn de gi yu. Nɔ giv ɔp!

` T-sεl limfoma, T-sεl Limfoma, limfoma, kεnsar, limf no dεm, nכn-Hכdgkin limfoma, kεnsar simptom dεm, kεnsar tritmεnt